Market Cap 11.46M
Revenue (ttm) 37.32M
Net Income (ttm) -17.76M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -47.59%
Debt to Equity Ratio -0.93
Volume 190,800
Avg Vol 206,892
Day's Range N/A - N/A
Shares Out 10.14M
Stochastic %K 81%
Beta 0.53
Analysts Strong Sell
Price Target $6.00

Company Profile

Biofrontera Inc., a biopharmaceutical company, engages in the commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. The company's products are used for the treatment of actinic keratoses, which are pre-cancerous skin lesions, as well as impetigo, a common skin infection. It offers Ameluz, a prescription drug for use in combination with the RhodoLED lamp series, for photodynamic therapy for the lesion-directed and field-directed treatmen...

Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Phone: 781 245 1325
Address:
120 Presidential Way, Suite 330, Woburn, United States
StockHolms
StockHolms Oct. 24 at 4:27 AM
$BFRI • On October 23, 2025, Biofrontera Inc. closed the restructuring agreement with Biofrontera AG. Under the deal, Inc. acquired all U.S. rights to Ameluz® and the lamp device series RhodoLED® (including the NDA, IND, manufacturing contracts, IP and relevant personnel) from AG.  • The royalty structure changes to ~12% of U.S. net sales up to $65 m, and 15% if above that threshold — replacing the previous transfer-pricing model of roughly 25%-35% of net sales per unit (tube) in the U.S. market.  The restructuring is expected to result in improved gross margins for the U.S. business of Inc., starting late Q4 2025 / early Q1 2026.  By reducing the heavy royalty/transfer-pricing burden, Biofrontera Inc. = clear path toward profitability. The lower 12-15% earn out instead of 25-35% gives more margin. • Inc. now owns the full U.S. rights = greater operational flexibility in the U.S. • U.S. revenue growth has more direct benefit for Inc.’s bottom line.
0 · Reply
StockHolms
StockHolms Oct. 23 at 7:47 PM
$BFRI Heading in the right direction off some positive news and a runway for profits.
0 · Reply
Tboonepickem
Tboonepickem Oct. 23 at 12:45 PM
$BFRI A lot of volatility between .98 and 1.08 in the PM this morning. No news, no volume. 🤔
0 · Reply
ivo98
ivo98 Oct. 23 at 11:44 AM
$BFRI Q3 ER before or after November 13 will make a difference 🤔🤫
0 · Reply
Bulltrader988
Bulltrader988 Oct. 20 at 10:25 PM
$BFRI ...👃👀 https://finviz.com/quote.ashx?t=BFRI&ty=c&ta=1&p=d
0 · Reply
Dijon02
Dijon02 Oct. 16 at 11:37 AM
$BFRI wen profits????
0 · Reply
Tboonepickem
Tboonepickem Oct. 15 at 12:18 AM
$BFRI Wow, it took so long to climb penny by penny to 1.07-1.09 range and then agent orange crushed gains on Friday. I guess it will be another 60 days before we see +1 again?!?!
0 · Reply
ivo98
ivo98 Oct. 14 at 8:16 PM
$BFRI they will pump it before 13 November 🤫😇
0 · Reply
Bulltrader988
Bulltrader988 Oct. 11 at 6:30 PM
$BFRI ...👃👀 https://finviz.com/quote.ashx?t=BFRI&ty=c&ta=1&p=d
0 · Reply
Bulltrader988
Bulltrader988 Oct. 8 at 10:35 PM
$BFRI break it 👃👀 https://finviz.com/quote.ashx?t=BFRI&ty=c&ta=1&p=d
0 · Reply
Latest News on BFRI
Biofrontera Inc. (BFRI) Q1 2025 Earnings Call Transcript

May 16, 2025, 3:36 PM EDT - 5 months ago

Biofrontera Inc. (BFRI) Q1 2025 Earnings Call Transcript


Biofrontera Inc. (BFRI) Q4 2024 Earnings Call Transcript

Mar 21, 2025, 11:20 AM EDT - 7 months ago

Biofrontera Inc. (BFRI) Q4 2024 Earnings Call Transcript


Biofrontera Inc. (BFRI) Q3 2024 Earnings Call Transcript

Nov 14, 2024, 3:02 PM EST - 1 year ago

Biofrontera Inc. (BFRI) Q3 2024 Earnings Call Transcript


Biofrontera Inc. (BFRI) Q2 2024 Earnings Call Transcript

Aug 15, 2024, 1:34 PM EDT - 1 year ago

Biofrontera Inc. (BFRI) Q2 2024 Earnings Call Transcript


Biofrontera Inc. (BFRI) Q1 2024 Earnings Call Transcript

May 16, 2024, 2:44 PM EDT - 1 year ago

Biofrontera Inc. (BFRI) Q1 2024 Earnings Call Transcript


Biofrontera Inc. (BFRI) Q4 2023 Earnings Call Transcript

Mar 18, 2024, 12:13 PM EDT - 1 year ago

Biofrontera Inc. (BFRI) Q4 2023 Earnings Call Transcript


StockHolms
StockHolms Oct. 24 at 4:27 AM
$BFRI • On October 23, 2025, Biofrontera Inc. closed the restructuring agreement with Biofrontera AG. Under the deal, Inc. acquired all U.S. rights to Ameluz® and the lamp device series RhodoLED® (including the NDA, IND, manufacturing contracts, IP and relevant personnel) from AG.  • The royalty structure changes to ~12% of U.S. net sales up to $65 m, and 15% if above that threshold — replacing the previous transfer-pricing model of roughly 25%-35% of net sales per unit (tube) in the U.S. market.  The restructuring is expected to result in improved gross margins for the U.S. business of Inc., starting late Q4 2025 / early Q1 2026.  By reducing the heavy royalty/transfer-pricing burden, Biofrontera Inc. = clear path toward profitability. The lower 12-15% earn out instead of 25-35% gives more margin. • Inc. now owns the full U.S. rights = greater operational flexibility in the U.S. • U.S. revenue growth has more direct benefit for Inc.’s bottom line.
0 · Reply
StockHolms
StockHolms Oct. 23 at 7:47 PM
$BFRI Heading in the right direction off some positive news and a runway for profits.
0 · Reply
Tboonepickem
Tboonepickem Oct. 23 at 12:45 PM
$BFRI A lot of volatility between .98 and 1.08 in the PM this morning. No news, no volume. 🤔
0 · Reply
ivo98
ivo98 Oct. 23 at 11:44 AM
$BFRI Q3 ER before or after November 13 will make a difference 🤔🤫
0 · Reply
Bulltrader988
Bulltrader988 Oct. 20 at 10:25 PM
$BFRI ...👃👀 https://finviz.com/quote.ashx?t=BFRI&ty=c&ta=1&p=d
0 · Reply
Dijon02
Dijon02 Oct. 16 at 11:37 AM
$BFRI wen profits????
0 · Reply
Tboonepickem
Tboonepickem Oct. 15 at 12:18 AM
$BFRI Wow, it took so long to climb penny by penny to 1.07-1.09 range and then agent orange crushed gains on Friday. I guess it will be another 60 days before we see +1 again?!?!
0 · Reply
ivo98
ivo98 Oct. 14 at 8:16 PM
$BFRI they will pump it before 13 November 🤫😇
0 · Reply
Bulltrader988
Bulltrader988 Oct. 11 at 6:30 PM
$BFRI ...👃👀 https://finviz.com/quote.ashx?t=BFRI&ty=c&ta=1&p=d
0 · Reply
Bulltrader988
Bulltrader988 Oct. 8 at 10:35 PM
$BFRI break it 👃👀 https://finviz.com/quote.ashx?t=BFRI&ty=c&ta=1&p=d
0 · Reply
Bulltrader988
Bulltrader988 Oct. 7 at 8:26 PM
$BFRI ... waiting for breakout 👃👀 https://finviz.com/quote.ashx?t=BFRI&ty=c&ta=1&p=d
0 · Reply
Bulltrader988
Bulltrader988 Oct. 4 at 12:50 PM
$BFRI more and more interesting 👃👀 https://finviz.com/quote.ashx?t=BFRI&ty=c&ta=1&p=d
0 · Reply
Bulltrader988
Bulltrader988 Oct. 3 at 7:42 AM
$BFRI interesting spot 👃👀 https://finviz.com/quote.ashx?t=BFRI&ty=c&ta=1&p=d
0 · Reply
LoveNvidia
LoveNvidia Oct. 3 at 2:59 AM
Looks like volume & momentum could be shifting in to ASTC! Tiny float getting a lot of attention and could explode upwards on volume. Watchers on ASTC are growing very fast and it could be the potential top runner for this week! Starting its 300% run - keep it on watch! Also watching for breakout: $HSDT $BFRI $DOGZ $TC $TVGN news
0 · Reply
Bulltrader988
Bulltrader988 Oct. 1 at 9:53 PM
$BFRI chart looks good 👃👀 https://finviz.com/quote.ashx?t=BFRI&ty=c&ta=1&p=d
0 · Reply
ivo98
ivo98 Sep. 30 at 10:26 AM
$BFRI Dieses Wachstum kann jedoch nicht linear betrachtet werden, da im ersten Halbjahr 2024 aufgrund einer Änderung der Lagerhaltungspolitik von Biofrontera Inc. keine Ameluz®-Verkäufe an unseren US-Partner getätigt wurden. Sämtliche Umsätze in diesem Zeitraum entfielen ausschließlich auf Lampenverkäufe sowie den Verkauf von Mustern. Ab dem vierten Quartal 2024 begann Biofrontera Inc. jedoch, sein übliches Ameluz®-Bestellvolumen wieder aufzunehmen, ein Trend, der sich im ersten Halbjahr 2025 fortsetzte.
0 · Reply
Hard2beLong
Hard2beLong Sep. 29 at 10:45 PM
$BFRI well done! No one yet noticed it.. tomorrow will add here
2 · Reply
ivo98
ivo98 Sep. 28 at 7:13 AM
$BFRI has nothing to do with Bfri. These are Bfra shares (Biofrontera AG).
0 · Reply
Bulltrader988
Bulltrader988 Sep. 27 at 7:38 PM
$BFRI Form 3 filled yesterday 👃👀 DEUTSCHE BALATON AKTIENGESELLSCHAFT.. "...Explanation of Responses: 1. The reported shares are held directly by Biofrontera AG. The Reporting Person and its affiliates collectively hold approximately 62.2% of the outstanding voting stock of Biofrontera AG and therefore may be deemed to beneficially own the shares owned by Biofrontera AG. The Reporting Person disclaims beneficial ownership of the reported securities except to the extent of its indirect pecuniary interest therein, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose...." 👃👀 https://www.sec.gov/Archives/edgar/data/1571071/000121390025092403/xslF345X02/ownership.xml
0 · Reply
ivo98
ivo98 Sep. 26 at 7:16 PM
$BFRI why don't we see the executed orders in the graphics on Nasdaq, Yahoo finance and Webull?
0 · Reply
Bulltrader988
Bulltrader988 Sep. 26 at 6:42 PM
$BFRI "... announced that it will participate in a webcast presentation and host one-on-one meetings with investors at the Lytham Partners Fall 2025 Investor Conference, taking place virtually on Tuesday, September 30, 2025... The webcast presentation will take place at 1:15 p.m. ET on Tuesday, September 30, 2025...." 👃👀 https://www.stocktitan.net/news/BFRI/biofrontera-inc-to-participate-in-the-lytham-partners-fall-2025-452xl1zslnis.html
0 · Reply
ivo98
ivo98 Sep. 25 at 9:52 AM
$BFRI https://www.hcplive.com/view/spotlighting-data-clearance-actinic-keratosis-using-tirbanibulin-neal-bhatia-md
0 · Reply